Диссертация (1174315), страница 21
Текст из файла (страница 21)
Biomarkers for osteoporosis management: utility in diagnosis,fracture risk prediction and therapy monitoring // Mol. Diagn. Ther.- 2008.- №3.Т.12.- P. 157-170.73. Gennari, L. Idiopathic osteoporosis in men / J.P. Bilezikian // Curr.Osteoporos. Rep.- 2013.- №4.- Т.11.- P. 286-298.74. Giusti, A. Treatment of primary osteoporosis in men / G. Bianchi // Clin.Interv. Aging.- 2014.- Dec 30.- P. 105-115. DOI: 10.2147/CIA.S4405775. Giusti, A. Male osteoporosis. / G. Bianchi // Reumatismo.- 2014.- Jul 28.66(2).- 136-43.
doi: 10.4081/reumatismo.2014.78676. Girón-Prieto, M.S. Bone remodeling markers as lithogenic risk factors inpatients with osteopenia-osteoporosis / A.S. Salvador, C. María, C. García // IntUrol Nephrol.- 2016.- Nov;48(11).- P. 1777-1781.77. Goh, L.H. Male osteoporosis: clinical approach and management in familypractice / C.H. How, T.C. Lau // Singapore. Med. J.- 2014.- №7.- Т.55.- P.
353357.78. Golob, A.L. Osteoporosis: screening, prevention, and management / M.B.Laya // Med. Clin. North Am.- 2015.- №3.- Т.99.- P. 587-606.79. Goetz, L.G. Cross-sex testosterone therapy in ovariectomized mice: additionof low-dose estrogen preserves bone architecture / R. Mamillapalli, M.J. Devlin,A.E. Robbins [et al.] // Am. J.
Physiol. Endocrinol. Metab.- 2017.- Nov 1; 313(5).P. 540-551.80. Golds, G. Male Hypogonadism and Osteoporosis: The Effects, ClinicalConsequences, and Treatment of Testosterone Deficiency in Bone Health / D.Houdek, T. Arnason // Int. J. Endocrinol.- 2017. P. 1-15.81. Goemaere, S. Inverse association between bone turnover rate and bonemineral density in community-dwelling men >70 years of age: no major role of sexsteroid status / I. Van Pottelbergh, H. Zmierczak, K. Toye [et al.] // Bone.- 2001.Sep;29(3).- P. 286-291.12782.Greenberg,C.R.Infantilehypophosphatasia:localizationwithinchromosome region 1p36.1-34and prenatal diagnosis using linked DNA markers /J.A. Evans, S.
McKendry-Smith // Am. J. Hum. Genet.-1990.- 46(2).- P. 286-292.83. Ghada, E.D. Bone Density, Osteocalcin and Deoxypyridinoline for EarlyDetection of Osteoporosis in Obese Children / H. Ashry, T. Ibrahim, T. Elias [etal.] // Open. Access. Maced. J. Med. Sci.- 2015. Sep 15; 3(3). P. 413–419.84.
Hagino, H. Increased bone mineral density with monthly intravenousibandronate contributes to fracture risk reduction in patients with primaryosteoporosis: three-year analysis of the MOVER study / S. Yoshida, J. Hashimoto,M. Matsunaga [et al.] // Calcif. Tissue. Int.- 2014.- Dec;95(6).- P. 557-563.85. Hernandez, C.J.
A theoretical analysis of the changes in basic multicellularunit activity at menopause. / G.S. Beaupré, D.R. Carter // Bone.- 2003.Apr;32(4).- P. 357-363. PMID: 1268967886. Henriksen, K. Role of biochemical markers in the management ofosteoporosis / C. Christiansen, M.A. Karsdal // ClimacteОic.- 2015.- 18 Suppl 2.P. 10-18.87. Hofbauer, L.C. Approach to the patient with secondary osteoporosis / C.Hamann, P.R.
Ebeling // Eur. J. Endocrinol.- 2010.-. №6.- Т.162.- P. 1009-1020.88. Hopkins, R.B. Estimation of the lifetime risk of hip fracture for women andmen in Canada / E. Pullenayegum, R. Goeree, J.D. Adachi [et al.] // Osteoporos.Int.- 2012.-. №3.- Т.23.- P. 921-927. DOI: 10.1007/s00198-011-1652-889. Hirofumi, T. Assessment of Etidronic Acid Plus Alfacalcidol for theTreatment of Osteopenia in Steroid-Dependent Asthmatics / N.
Mutsuo, Y.Tadashi, T. Shingo [et al.] // Clin. Drug. Invest.- 2003.-23(2).- P. 99-105.90. Icks, A. Trend of hip fracture incidence in Germany 1995-2004: apopulation-based study / B. Haastert, M. Wildner, C. Becker // Osteoporos. Int.2008.- Aug;19(8). P. 1139-1145.91. IOF Osteoporosis in men [electronic resource] // 2019.- Access modehttp://www.iofbonehealth.org/osteoporosis-men12892.
ISCD Official Positions - Adult [electronic resource] // 2015.- Access modehttps://www.iscd.org/official-positions/2015-iscd-official-positions-adult93. Janina, M. P. Trabecular bone microstructure and local gene expression iniliac crest biopsies of men with idiopathic osteoporosis / T. Kohler, A.Berzlanovich, C. Muschitz [et al.]// J. Bone. Miner. Res.- 2011.- Jul;26(7). P.1584-1592.94. Johnell, O. Mortality, morbidity, and assessment of fracture risk in maleosteoporosis / J. Kanis, G. Gullberg // Calcif. Tissue Int.- 2001.- №4.- Т.69.- P.182-184.
PMID: 1173024595. Jiang H.X. Development and initial validation of a risk score for predictingin-hospital and 1-year mortality in patients with hip fractures / S.R. Majumdar,D.A. Dick, M. Moreau // J. Bone. Miner. Res.- 2005.- Mar;20(3). P. 494-500.96. Jung, S.L.M.D. Pediatric dual-energy X-ray absorptiometry: interpretationand clinical and research application // Korean. J. Pediatr.- 2010.- Mar;53(3). P.286-293.97. Kanis, J.A. Alcohol intake as a risk factor for fracture / H.
Johansson, O.Johnell, A. Oden // Osteoporos. Int.- 2005.- 16.- P. 737-742.98. Kanis, J.A. Towards a diagnostic and therapeutic consensus in maleosteoporosis / G. Bianchi, J.P. Bilezikian, J.M. Kaufman [et al.] // Osteoporos. Int.2011.- №11.- Т.22.- P. 2789-2798.99. Kanis, J. European guidance for the diagnosis and management ofosteoporosis in postmenopausal women / E. McCloskey, H. Johansson, C. Cooper[et al.] // Osteoporosis. International.- 2013.- 24(1).
P. 23-57.100. Kannegaard, P.N. Excess mortality in men compared with womenfollowing a hip fracture. National analysis of comedications, comorbidity andsurvival / S. van der Mark, P. Eiken, B. Abrahamsen // Age. Ageing.- 2010.- №2.Т.39.- P. 203-209.101. Kapoor, D. Smoking and hormones in health and endocrine disorders / T.H.Jones // Eur. J. Endocrinol.- 2005.- Apr;152(4).- P. 491-499.129102. Kennes, B. Early biochemical events associated with lymphocyte activationin ageing. I.
Evidence that Ca⁺ ⁺ dependent processes induced by PHA areimpaired / C. Hubert, D. Brohee, P. Neve // Immunology.- 1981.- Jan;42(1).- P.119-26.103. Kenneth, D. A meta-analysis of the effects of cigarette smoking on bonemineral density / W.C. Klesges, R. C. Klesges // Calcif. Tissue. Int.- 2001.- May;68(5).- P. 259-270.104. Khosla, S. Forum on aging and skeletal health: summary of the proceedingsof an ASBMR workshop / T.M. Bellido, M.K. Drezner, C.M. Gordon [et al.] // J.Bone. Miner.
Res.- 2011.- Nov;26(11).- P. 2565-2578. DOI: 10, 1002 / jbmr.488105. Kiebzak, G.M. Undertreatment of osteoporosis in men with hip fracture /G.A. Beinart, K. Perser, C.G. Ambrose [et al.] // Arch. Intern. Med.- 2002.- №19.Т.162.- P. 2217-2222. PMID: 12390065106. Korpi-Steiner, N. Osteoporosis in men / D. Milhorn, C. Hammett-Stabler //Clin. Biochem.- 2014.- №10-11.- Т.47.- P. 950-959.107. Kochupillai, N.
The physiology of vitamin D: current concepts // Indian JMed. Res.- 2008.- Mar;127(3). P. 256-262.108. Lamy, O. Intravenous ibandronate in men with osteoporosis: an open pilotstudy over 2 years / L. Sandini, I. Pache, S. Fatio [et al.] // J. Endocrinol. Invest.2003.- №8.- Т.26.- P. 728-732.109. Lau, K.H. Vitamin D therapy of osteoporosis: plain vitamin D therapyversus active vitamin D analog (D-hormone) therapy / D.J. Baylink // Calcif.Tissue. Int.- 1999.- Oct; 65(4).- P. 295-306.110. Lau, E.
Mortality following the diagnosis of a vertebral compressionfracture in the Medicare population / K. Ong, S. Kurtz, J. Schmier [et al.] // J.Bone. Joint. Surg. Am.- 2008.- Jul; 90(7).- P. 1479-1486. PMID: 18594096111. Lee, J. Current recommendations for laboratory testing and use of boneturnover markers in management of osteoporosis / S.
Vasikaran // Ann. Lab. Med.2012.- 32.- P. 105-112. DOI: 10.3343/alm.2012.32.2.105130112. Leibbrandt, A. RANK/RANKL: regulators of immune responses and bonephysiology / J.M. Penninger // Ann. NY. Acad. Sci.- 2008.- 1143.- P. 123-150.113. Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in theelderly: consequences for bone loss and fractures and therapeutic implications //Endocr.
Rev.- 2001.- №4.- Т.22.- P. 477-501.114. Lips, P. Reducing fracture risk with calcium and vitamin D / R. Bouillon,N.M. van Schoor, D. Vanderschueren [et al.] // Clin. Endocrinol. (Oxf).- 2010.№3.- Т.73.- P. 277-285.115. Lorentzon, M. Osteoporosis: the evolution of a diagnosis / S.R. Cummings// J. Intern. Med.- 2015.- №6.- Т.277.- P. 650-661. DOI: 10,1111 / joim.12369116.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
